Dimethylformamide → 5,5-Dioxo-2-(pyrid-4-ylethylcarbonylamino)dibenzothiophene

HRID 1064003ノート

反応式

HRID 1064003 の反応式
[O:1]=[S:2]1(=[O:16])[C:6]2[CH:7]=[CH:8][CH:9]=[CH:10][C:5]=2[C:4]2[CH:11]=[C:12]([NH2:15])[CH:13]=[CH:14][C:3]1=2.[N+](C1C=CC(COC([NH:28][C:29]2C=[CH:40][C:32]3SC4C=C[CH:37]=[CH:36][C:35]=4[C:31]=3[CH:30]=2)=O)=CC=1)([O-])=O.CCN=C=NCCCN(C)C.CN(C=[O:59])C>>[O:1]=[S:2]1(=[O:16])[C:6]2[CH:7]=[CH:8][CH:9]=[CH:10][C:5]=2[C:4]2[CH:11]=[C:12]([NH:15][C:37]([CH2:36][CH2:35][C:31]3[CH:30]=[CH:29][N:28]=[CH:40][CH:32]=3)=[O:59])[CH:13]=[CH:14][C:3]1=2

参加物

5

反応物 4

HCID 6228DimethylformamideHCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 149185295,5-Dioxo-2-aminodibenzothiopheneHCID 693158012-(4-Nitrobenzoxycarbonylamino)dibenzothiophene

生成物 1

HCID 693151165,5-Dioxo-2-(pyrid-4-ylethylcarbonylamino)dibenzothiophene

実験手順

5,5-Dioxo-2-aminodibenzothiophene (J Med Chem, (1994), 37 (13), 2085-9; 115 mg, 0.5 mmol) was dissolved in DMF (2.0 ml) and 3-(pyridin-4-yl)propionic acid (Method 1; 75 mg, 0.5 mmol) was added in one portion followed by EDAC (115 mg, 0.5 mmol) and the resultant mixture was stirred for 72 hours at ambient temperature: It was then poured onto water (50 ml) and extracted with DCM (2-50 ml), dried and evaporated in vacuo. The residue thus obtained was purified by chromatography (Bond Elut column) eluted with 0-5.0% methanol in DCM to give the product as a colourless solid (31.8 mg). NMR 10.52 (brs, 1H), 8.46 (d, 2H), 8.32 (d, 1H), 7.97 (d, 1H), 7.94 (d, 1H), 7.88 (d, 1H), 7.76 (d, 1H), 7.70 (t, 1H), 7.64 (t, 1H), 7.26 (d, 2H), 2.93 (t, 2H), 2.75 (t, 2H); m/z 365.

後処理

  1. additionIt was then poured onto water (50 ml)
  2. extractionextracted with DCM (2-50 ml)
  3. customdried
  4. customevaporated in vacuo
  5. customThe residue thus obtained
  6. customwas purified by chromatography (Bond Elut column)
  7. washeluted with 0-5.0% methanol in DCM

出典と根拠

ORDレコード
ord-05506dd271e14b56bef55778e2633097
出典データセット
uspto-grants-2005_11
特許番号
US06967216B2

反応ノート

読み込み中…